{"id":8152,"date":"2016-06-27T00:02:06","date_gmt":"2016-06-27T00:02:06","guid":{"rendered":"\/?p=8152"},"modified":"2016-06-27T00:15:07","modified_gmt":"2016-06-27T00:15:07","slug":"relmada-therapeutics-inc-otcmktsrlmd-slips-again","status":"publish","type":"post","link":"\/articles\/relmada-therapeutics-inc-otcmktsrlmd-slips-again\/","title":{"rendered":"Relmada Therapeutics Inc (OTCMKTS:RLMD) Slips Again"},"content":{"rendered":"\n<p><img decoding=\"async\" style=\"color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 11px; float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/93\/93799\/rlmd_6m_450x350.png\" border=\"0\" \/>The last time we covered Relmada Therapeutics Inc (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a>) was back in April when the ticker had embarked on an upward run that could have pushed it to $4 per share. Unfortunately, that didn&rsquo;t happen and <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a> lost some of the value it had gained, dropping to almost $2 per share in the first half of May.<\/p>\n<p>&nbsp;<\/p>\n<p>The most probable reason for the upward run back then was the company&rsquo;s update on its NASDAQ application and the fact that it only had to reach a price of $4 a pop to cover the requirements for uplisting. That, however, didn&rsquo;t happen and <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a><\/strong> remains a pretty decent OTC marketplace company with the following financials.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>cash: $11.34 million<\/li>\n<li>current assets: $11.77 million<\/li>\n<li>current liabilities: $2.4 million<\/li>\n<li>revenues: ZERO<\/li>\n<li>loss from operations: $2.74million<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>These numbers show us that <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a><\/strong> is actually a pretty decent development stage company with impressive cash reserves. This makes the $30 million market valuation seem a bit small, compared to other OTC entities that have far less to show.<\/p>\n<p>&nbsp;<\/p>\n<p>Still, the company stock has a hard time attracting investor interest and keeping the confidence. It is rather strange that even optimistic press releases like the one <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a><\/strong> posted on June 7 aren&rsquo;t able to provide the stock with a decent upward push.<\/p>\n<p>&nbsp;<\/p>\n<p>Meanwhile, <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RLMD\">RLMD<\/a><\/strong> lost 6.03% of its value yesterday and finished the session with a price of $2.65. A total of 33 thousand shares changed their hands, generating $88 thousand in daily dollar volume, showing the lack of interest in the company stock.<\/p>\n<p>&nbsp;<\/p>\n<p>The ticker is still slipping today and you would do well to do your due diligence and weigh out the risks before putting any money on the line.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The last time we covered Relmada Therapeutics Inc (OTCMKTS:RLMD) was back in April when the ticker had embarked on an upward run that could have pushed it to $4 per share. Unfortunately, that didn&rsquo;t&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2009],"class_list":["post-8152","post","type-post","status-publish","format-standard","hentry","category-news","tag-rlmd"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=8152"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8152\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=8152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=8152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=8152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}